N-(Azetidin-3-yl)pyrimidin-2-amine dihydrochloride, 1g

EDTA copper disodium salt x H2O, min. 99%, for synthesis, 250 g, plastic packaging.

(1R,2R)-2-Aminocyclopentane-1-carboxylic acid hydrochloride, 97%, 1g

N-Boc-D-tert-leucine, 97.0%, 5g

h-dapa-oh.hbr, 95.0%, 1g

(E)-1-(4-((4-Ethoxybenzylidene)amino)phenyl)ethan-1-one, 98%, 5g

7-Methoxy-benzo[1,3]dioxole-5-carbaldehyde, 97.0%, 5g

(5-Methoxy-1-methyl-1h-pyrazol-3-yl)methanol, 95%, 250mg

(2'-Methyl-[1,1'-biphenyl]-2-yl)diphenylphosphine, 95.0%, 25g

(S)-2-Amino-4-methoxy-4-oxobutanoic acid hydrochloride, 95.0%, 10g

N-(2-methyl-5-nitrophenyl)acetamide, 95+%, 250mg

1,3,5-Tri(1-naphthyl)benzene>98.0%(HPLC)1g

Cefotiam hexetil hydrochloride, 95.72%, 1mg